Endometriosis & Palmitoylethanolamide (PEA)
Exciting new research published in the International Journal of Women’s Health has confirmed the efficacy of ultra-micronized Palmitoylethanolamide in the treatment of Endometriosis.
Endometriosis is an estrogen-dependent chronic benign inflammatory disease characterised by the presence and growth of endometrial tissue outside uterine cavity, most commonly in pelvic organs and peritoneum and in some rare cases in extra-abdominal locations.
Results revealed that all patients showed a significant improvement in chronic pelvic pain, deep dyspareunia, dysmenorrhea, dyschezia, as well as in quality of life and psychological well-being.
So, if you or someone you love is suffering from Endometriosis, contact Elixir today.